查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1435308

2024 年细胞化验分析全球市场报告

Cell Based Assays Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

细胞化验分析的市场规模预计在未来几年将快速成长。预计到 2028 年将以 11.7% 的复合年增长率 (CAGR) 增长至 418.6 亿美元。预测期内的预期成长主要归因于人工智慧和机器学习的整合、不断变化的监管环境、对高内容筛检的需求不断增加、疾病建模的进步以及对精准医疗的关注。这段时期的主要趋势包括高通量筛检（HTS）的采用、3D细胞培养的使用、晶片上器官技术的实施、CRISPR/Cas9技术的应用以及成像技术的进步。

基于细胞的阵列在研究中的使用正在增加，因此需要在药物发现中转向更具预测性的细胞模型，以减少后期失败。製药业迫切需要有效地将药物推向市场并减少代价高昂的后期失败，这是细胞化验分析创新的关键驱动力。新药临床实验（IND）III期临床试验的失败可能会为公司带来高达数亿美元的重大财务损失。 Sigma的报告显示，考虑到目前的后期失败率，製药公司的收益可能会骤降至5%，这对大多数公司来说是不可接受的水平。高内涵系统和细胞化验分析中资料分析的显着增强使科学家能够提取有关细胞反应的更多信息，支持药物发现中的明智决策，这将进一步推动基于阵列的市场的增长。

生技药品销售的预期成长将推动细胞化验分析市场向前发展。生技药品，包括生物来源药物，如疫苗、血液成分、基因疗法和治疗性蛋白质，依靠细胞化验分析来评估功能、功效、安全性和生物相似性。例如，2023年加拿大政府报告称，2021年生技药品销售额超过110亿美元。电子付款的普及也推动了细胞化验分析市场的发展。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球细胞化验分析市场，按产品和服务细分、性能和预测，2018-2023、2023-2028、2033
  • 消耗品
  • 装置
  • 服务
  • 软体
  • 全球细胞化验分析市场，依技术细分，实际与预测，2018-2023、2023-2028、2033
  • 自动处理
  • 流式细胞技术
  • 无标定检测
  • 高通量筛检
  • 其他技术
  • 全球细胞化验分析市场，按应用细分、实际和预测，2018-2023、2023-2028、2033
  • 药物发现
  • 基础调查
  • ADME研究
  • 预测毒理学
  • 其他用途
  • 全球细胞化验分析市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 製药和生物技术公司
  • 学术和政府研究机构
  • 受託研究机构（CRO）
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球细胞化验分析市场，按地区、表现和预测，2018-2023、2023-2028、2033
  • 全球细胞化验分析市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 细胞化验分析市场的竞争形势
  • 细胞化验分析市场公司概况
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company

第31章 其他大型创新公司

  • GE HealthCare Technologies Inc.
  • Corning Incorporated
  • Lonza Group Ltd.
  • Charles River Laboratories International Inc.
  • PerkinElmer Inc.
  • Sigma-Aldrich Corporation
  • Bio-Rad Laboratories Inc.
  • Miltenyi Biotec GmbH
  • Abcam plc
  • BioVision Inc.
  • Promega Corporation
  • Caliper Life Sciences Inc.
  • Cell Signaling Technology Inc.
  • BioTek Instruments Inc.
  • Enzo Life Sciences Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r15022

Cell-based assays are experimental tools designed for studying reactions occurring inside cells, allowing researchers to investigate various mechanisms and processes related to cellular function.

The main products and services associated with cell-based assays include consumables, instruments, services, and software. Consumables are items that are used up or depleted during their usage. Instruments commonly used in cell-based assays encompass microplates, microplate readers, high-throughput screening systems, and liquid handling systems. Various consumables essential for these assays include reagents and media, cells and cell lines, probes, and labels. Cell-based assays employ different technologies, such as automated handling, flow cytometry, label-free detection, high-throughput screening, among others. These assays find applications in drug discovery, basic research, ADME (Absorption, Distribution, Metabolism, and Excretion) studies, predictive toxicology, and other research purposes. End-users of cell-based assays include pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs), and others.

The cell-based assays market research report is one of a series of new reports from The Business Research Company that provides cell-based assays market statistics, including cell-based assays industry global market size, regional shares, competitors with a cell-based assays market share, detailed cell-based assays market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-based assays industry. This cell-based assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell based assays market size has grown strongly in recent years. It will grow from $24.61 billion in 2023 to $26.9 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth observed during the historic period in the field of cell-based assays can be attributed to several factors, including the emergence of high-throughput screening (HTS) techniques, the integration of automation, the utilization of biomarker detection methods, the adoption of microfluidics, and the introduction of gene editing tools.

The cell based assays market size is expected to see rapid growth in the next few years. It will grow to $41.86 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth expected in the forecast period is primarily due to the integration of AI and machine learning, a shift in the regulatory landscape, increased demand for high-content screening, advancements in disease modeling, and a focus on precision medicine. Key trends during this period include the adoption of high-throughput screening (HTS), the utilization of 3D cell cultures, the implementation of organ-on-a-chip technology, the application of CRISPR/Cas9 technology, and progress in imaging techniques.

The utilization of cell-based arrays in research is on the rise, necessitating a shift towards more predictive cellular models in drug discovery to mitigate last-stage failures. The pharmaceutical industry's imperative to effectively bring drugs to market and mitigate costly late-stage failures is a key driver in the innovation of cell-based assays. Failure in Phase III clinical trials of investigational new drugs (IND) can result in substantial financial losses, reaching several hundred million dollars for the company. Sigma's report indicates that the return on investment for pharmaceutical companies could plummet to 5% given the current rate of late-stage failures, an unacceptable level for most companies. Significant enhancements in high-content systems and data analysis in cell-based assays empower scientists to extract more information about cellular responses, aiding informed decision-making in drug discovery and further fueling the growth of the cell-based array market.

The anticipated increase in biologics sales is set to propel the cell-based assays market forward. Biologics, encompassing medicines derived from living organisms, including vaccines, blood components, gene therapies, and therapeutic proteins, rely on cell-based assays for evaluating functionality, potency, safety, and bio-similarity. For example, in 2023, the Government of Canada reported biologics sales exceeding $11 billion in 2021. The surge in electronic payment methods is also contributing to the drive in the cell-based assays market.

The primary factor constraining the global cell-based assay market is the high cost of instruments. The elevated prices of instrumentation can diminish the return on investments (ROI) due to low adaptation. Biotek's development of HCA (high content analysis) instruments, while advanced, comes with a high price tag, limiting accessibility to industrial end-users or core labs with sufficient capital budgets. This restriction prevents low-budget end-users from fully leveraging cell-based assays, thereby impeding market growth.

Researchers are increasingly leaning towards early-phase predictive toxicity testing to avert late-stage drug failures. The scaling up of predictive cell toxicity assays aims to increase compound screening in the early stages of drug development, reducing the cost of failure. For instance, Creative Bioarray, a biotech company, offers a range of in vitro toxicity services to assess drug-induced toxicities, saving time and costs by minimizing the risk of failure in earlier stages. These advancements aim to simplify clinical testing and reduce operational costs.

Leading companies in the cell-based assays market are introducing new platforms, such as cell-based phenotypic assay platforms, to provide advanced solutions for drug discovery. A cell-based phenotypic assay platform is a system in drug discovery that evaluates cellular responses to compound treatments by integrating advanced imaging and analytical tools, powered by artificial intelligence. In February 2021, Selvita, a Poland-based biotechnology company, launched a new cell-based phenotypic assay platform for drug discovery, targeting areas such as neuroinflammatory and fibrotic diseases. This advanced platform integrates high-content imaging systems with artificial intelligence to enhance drug profiling and mechanism of action studies, aiming to expedite the drug discovery process. The platform enhances Selvita's offerings for pharmaceutical and biotech companies looking to leverage AI in drug discovery.

In May 2022, Cell Carta, a Canada-based provider of precision medicine laboratory services, acquired next-generation immune-MRM assays from Precision Assays for an undisclosed amount. This acquisition aims to strengthen Cell Carta's position in the proteomics vertical and enhance its service offerings in precision medicine laboratory services. Precision Assays, a US-based provider of next-generation targeted proteomics testing solutions, played a significant role in this strategic move.

Major companies operating in the cell based assays market report are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Miltenyi Biotec GmbH, Abcam PLC, BioVision Inc., Promega Corporation, Caliper Life Sciences Inc., Cell Signaling Technology Inc., BioTek Instruments Inc., Enzo Life Sciences Inc., BioAgilytix Labs LLC, Cisbio International LLC, ProQinase GmbH, QGel SA, Biotium Inc., Selexis SA, Aurelia Bioscience Ltd., Creative Bioarray, Cell Biolabs Inc., Essen BioScience Ltd., Eurofins Scientific SE, DiscoveRx Corporation

North America was the largest region in the cell-based assays market in 2023. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell based assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-based assay market consists of sales of reagents, cell lines, microplates, microplates, assay kits, probes, and labels. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Based Assays Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell based assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell based assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell based assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product & Service: Consumables; Instruments; Services; Software
  • 2) By Technology: Automated Handling; Flow Cytometry; Label-Free Detection; High-Throughput Screening; Other Technologies
  • 3) By Application: Drug Discovery; Basic Research; ADME Studies; Predictive Toxicology; Other Applications
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Government Research Institutes; Contract Research Organizations (CRO); Other End Users

Sub-segments

  • By Instruments: Microplates; Microplate Readers; High Throughput Screening; Liquid Handling Systems
  • By Consumables: Reagents And Media; Cells And Cell Lines; Probes And Labels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Based Assays Market Characteristics

3. Cell Based Assays Market Trends And Strategies

4. Cell Based Assays Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell Based Assays Market Size and Growth

  • 5.1. Global Cell Based Assays Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell Based Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell Based Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Based Assays Market Segmentation

  • 6.1. Global Cell Based Assays Market, Segmentation By Product & Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
  • Services
  • Software
  • 6.2. Global Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Automated Handling
  • Flow Cytometry
  • Label-Free Detection
  • High-Throughput Screening
  • Other Technologies
  • 6.3. Global Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Other Applications
  • 6.4. Global Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Government Research Institutes
  • Contract Research Organizations (CRO)
  • Other End Users

7. Cell Based Assays Market Regional And Country Analysis

  • 7.1. Global Cell Based Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell Based Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Based Assays Market

  • 8.1. Asia-Pacific Cell Based Assays Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Based Assays Market

  • 9.1. China Cell Based Assays Market Overview
  • 9.2. China Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Based Assays Market

  • 10.1. India Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Based Assays Market

  • 11.1. Japan Cell Based Assays Market Overview
  • 11.2. Japan Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Based Assays Market

  • 12.1. Australia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Based Assays Market

  • 13.1. Indonesia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Based Assays Market

  • 14.1. South Korea Cell Based Assays Market Overview
  • 14.2. South Korea Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Based Assays Market

  • 15.1. Western Europe Cell Based Assays Market Overview
  • 15.2. Western Europe Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Based Assays Market

  • 16.1. UK Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Based Assays Market

  • 17.1. Germany Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Based Assays Market

  • 18.1. France Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Based Assays Market

  • 19.1. Italy Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Based Assays Market

  • 20.1. Spain Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Based Assays Market

  • 21.1. Eastern Europe Cell Based Assays Market Overview
  • 21.2. Eastern Europe Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Based Assays Market

  • 22.1. Russia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Based Assays Market

  • 23.1. North America Cell Based Assays Market Overview
  • 23.2. North America Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Based Assays Market

  • 24.1. USA Cell Based Assays Market Overview
  • 24.2. USA Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Based Assays Market

  • 25.1. Canada Cell Based Assays Market Overview
  • 25.2. Canada Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Based Assays Market

  • 26.1. South America Cell Based Assays Market Overview
  • 26.2. South America Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Based Assays Market

  • 27.1. Brazil Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Based Assays Market

  • 28.1. Middle East Cell Based Assays Market Overview
  • 28.2. Middle East Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Based Assays Market

  • 29.1. Africa Cell Based Assays Market Overview
  • 29.2. Africa Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Based Assays Market Competitive Landscape And Company Profiles

  • 30.1. Cell Based Assays Market Competitive Landscape
  • 30.2. Cell Based Assays Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell Based Assays Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc.
  • 31.2. Corning Incorporated
  • 31.3. Lonza Group Ltd.
  • 31.4. Charles River Laboratories International Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. Sigma-Aldrich Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Miltenyi Biotec GmbH
  • 31.9. Abcam plc
  • 31.10. BioVision Inc.
  • 31.11. Promega Corporation
  • 31.12. Caliper Life Sciences Inc.
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioTek Instruments Inc.
  • 31.15. Enzo Life Sciences Inc.

32. Global Cell Based Assays Market Competitive Benchmarking

33. Global Cell Based Assays Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Based Assays Market

35. Cell Based Assays Market Future Outlook and Potential Analysis

  • 35.1 Cell Based Assays Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell Based Assays Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell Based Assays Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer